Collectively, FOXO3a is involved in regulating apoptosis, cell cycle arrest, drug resistance, and EMT, and glycolysis in breast cancer (Liu et al., 2022b; Sun et al., 2023) (Figure 2; Figure 3; Figure 4). The gene discussed is FOXO3; the disease is breast cancer.